Medical devices, healthcare technology and the business of care
PMA approval · P100022

ZILVER PTX DRUG-ELUTING PERIPHERAL STENT

Cook Ireland, Ltd. · Decision date Nov 14, 2012

FDA DECISIONP100022

What did the FDA approve?

FDA records P100022 as an original PMA application. The recorded decision is approval, dated Nov 14, 2012.

FDA approval order statement

APPROVAL FOR THE ZILVER PTX DRUG-ELUTING PERIPHERAL STENT. THIS DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETER FOR THE TREATMENT OF DE NOVO OR RESTENOTIC SYMPTOMATIC LESIONS IN NATIVE VASCULAR DISEASE OF THE ABOVE-THE-KNEE FEMOROPOPLITEAL ARTERIES HAVING REFERENCE VESSEL DIAMETERS FROM 4 MM TO 9 MM AND TOTAL LESION LENGTHS UP TO 140 MM PER LIMB AND 280 MM PER PATIENT.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Nov 14, 2012

FDA source record

Regulatory record facts

Identifier
P100022
Regulatory pathway
Premarket approval application
Product code
NIU
Decision code
APPR
Decision date
Nov 14, 2012
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, superficial femoral artery, drug-eluting.

Product code
NIU
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P100022 received

    Application receipt date recorded by FDA.

  2. P100022 · FDA decision

    APPR

  3. P100022/S046 · Related supplement

    Zilver PTX Drug-Eluting Peripheral Stent

Timeline entries are records held by MedtechLedger for P100022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100022

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cook Ireland, Ltd.

Headquarters
Not reported
Brand website
cookmedical.com
FDA applicant address
O' Halloran Rd., National Technology Park, Limerick

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records